Neurogene Announces Upcoming Presentation on the Therapeutic Rationale for ICV Delivery in CNS-Targeted Gene Therapy

PUBLISHED Tuesday, April 28, 2026 · Unknown

AI BRIEFING

⬤ Neurogene to Present on ICV Delivery in CNS-Targeted Gene Therapy
⬤ Company aims to demystify ICV route as a well-established neurosurgical procedure
⬤ ICV delivery strategy designed to maximize efficacy for CNS gene therapy